Energenesis Biomedical Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Energenesis Biomedical Co Ltd

Watchlist Manager

Watchlist

Price: 34.3 TWD 1.33% Market Closed

Market Cap: NT$3B

E	Energenesis Biomedical Co Ltd TWSE:6657	TW
A	Amgen Inc F:AMG	US
	MercadoLibre Inc BMV:MELIN	UY
	Cencora Inc NYSE:COR	US
M	Mitsui & Co Ltd DUS:MTS1	JP
	SoftBank Corp TSE:9434	JP
	Orient Overseas (International) Ltd HKEX:316	HK
	Sasol Ltd F:SAOA	ZA

Profitability Summary

Energenesis Biomedical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

75%

Strong 3Y Average Gross Margin

74%

Gross Margin is Increasing

71% > 75%

Negative Operating Margin

-2 866%

Negative 3Y Average Operating Margin

-3 538%

Operating Margin is Increasing

-4 079% > -2 866%

Negative Net Margin

-2 649%

Negative 3Y Average Net Margin

-3 352%

Net Margin is Increasing

-4 018% > -2 649%

Negative Free Cash Flow Margin

-2 021%

Negative 3Y Average Free Cash Flow Margin

-2 999%

Free Cash Flow Margin is Increasing

-3 843% > -2 021%

Negative ROE

-22%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-198%

ROIC is Increasing

-226% > -45%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.